You are here:
Home /
/ Johnson and Johnson Receives FDA Warning regarding DePuy Hip Implant
Johnson and Johnson Receives FDA Warning regarding DePuy Hip Implant
Washington, DC: Johnson and Johnson subsidiary DePuy Orthopaedics has reportedly received a warning from the US Food and Drug Administration (FDA) about its DePuy hip implant. The Johnson and Johnson subsidiary is the same company that marketed the DePuy hip replacement devices, which were recalled in 2010 and linked to a high failure rate. Those metal-on-metal hip devices are now the focus of multiple DePuy lawsuits in the US
